21 Oct 2018 | 5:53 AM
 

Ipca Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 524494 | NSE Symbol: IPCALAB
667.80
-2.54
(-0.38 %)
19 Oct 2018 | 03:51 PM
Change company
  • Open (Rs)
    665.00
  • Prev. close (Rs.)
    670.35
  • High (Rs.)
    675.95
  • Low (Rs.)
    656.70
  • 52W H (Rs.)
    822.80
  • 52W L (Rs.)
    444.00
  • Volume
    1246
  • MCap (Rs in Cr.)
    8,437.79
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
18.97
Operating Margin (%)
14.63
Gross Profit Margin (%)
9.22
Net Profit Margin (%)
7.29
Total Debt/Equity
0.18
Dividend payout Ratio (Net Profit)
6.34
Earning Retention Ratio
94.37

News

03 Oct 2018 - 11:17:00-Pharmaceutical firm Ipca Laboratories Wednesday announced the acquisition of 80 per cent stake in US...
29 May 2018 - 14:20:00-The company reported standalone net profit of Rs 51...
17 Jan 2018 - 10:00:00-Ipca Laboratories Ltd. has said that it has acquired 100 per cent share capital of Pisgah Labs Inc...
14 Nov 2017 - 15:01:00-The company reported standalone net profit of Rs 96...

Announcements

16-Oct-2018
Ipca Laboratorie - Shareholding for the Period Ended September 30 2018
13-Oct-2018
Ipca Laboratorie - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulat
12-Oct-2018
Ipca Laboratorie - Statement Of Investor Complaints For The Quarter Ended September 2018
10-Oct-2018
Ipca Laboratorie - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And
03-Oct-2018
Ipca Laboratorie - Acquisition

Religare Research

19 Oct 2018 | 07:00 PM
Nifty failed to cross the hurdle at 10,700 last week and ended with loss of nearly 1.5%, pressurized...
19 Oct 2018 | 06:00 PM
Nifty failed to cross resistance zone at 10,700 last week and slipped almost vertically thereafter. ...
19 Oct 2018 | 10:33 AM
• Gold edges higher as Asian shares slip • Oil prices edge up, but set for weekly loss on stock buil...
19 Oct 2018 | 10:18 AM
The rupee settled at 73.60 to a dollar, against 73.46 at previous close. The currency opened slightl...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
27,50,000 217.70 28.22 -1.86
27,50,000 217.70 50.36 -1.86
27,50,000 217.70 52.92 -1.86
27,50,000 217.70 34.02 -1.86
25,82,576 169.21 447.24 -2.22

Shareholding Pattern

       
Promotors46.07%
Mutual Funds/UTI22.11%
FI/Banks1.77%
Insurance1.77%
FII16.41%
Government0.00%
Others3.54%

Peer Group

Company Intraday Graph
 Merck Ltd.
2,819.80(-4.49)
3302
 AstraZeneca Pharma India Ltd.
1,678.95(1.58)
3274
 Ajanta Pharma Ltd.
1,000.45(-0.06)
3790
 Dr. Lal Pathlabs Ltd.
925.00(-2.90)
17140

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Ipca Laboratories Ltd.-82.70-72.45-30.95
NIFTY(S&P CNX)-930.80-706.65-261.75
BSE SENSEX-2,805.59-2,180.74-111.66
BSE 500-1,434.30-1,030.59-1,124.01

Corporate Details

Key Personal
Ajit Kumar Jain
Joint Managing Director & CFO
Pranay Godha
Executive Director
Prashant Godha
Executive Director
Key Address
Registered Office
48 Kandivli Industrial Estate Kandivli (West),Mumbai,Maharashtra

Tel:022-66474444 62106050, Fax:022-28686613

investors@ipca.com
http://www.ipca.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :44 Community Center 2nd Floor Naraina Industrial Area Phase I Near PVR Naraina